SlideShare une entreprise Scribd logo
1  sur  8
UCSF Lean Launchpad For Life Science
and Healthcare Startups
Medical Device Track
Class 3
Channels
October 15, 2013
Allan May
Chairman, Life Science Angels
amay@lifescienceangels.com
UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE MARKETS ARE
PHYSICAL MARKETS


Medical devices encompass a large range of tangible and intangible
items with a wide variety of business models and issues











Imaging equipment, such as MRI, CT and ultrasound
Therapeutic capital equipment, such as Stereotactic radiosurgery, lasers, and
surgical robots
Implants, such as total joints, pacemakers, stents, and artificial corneas
Instruments and tools, such as scalpels, syringes, and electrocautery
Devices, such as catheters, introducers, and sheaths
Monitoring equipment, such as glucometers, pulse oximetry, and vital signs
monitors
Durable medical equipment, such as crutches, wheelchairs, and home oxygen
Disposables, such as syringes, wound dressings, and casts

Medical devices generally require physical delivery


Exceptions:
 Software based products
 Morpheus: Enhanced imaging data via post processing
 Physician office management software
 Big Data based products

UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE CHANNELS TEND TO BE DIRECT



Most devices are sold to hospitals, physicians or patients directly
Most medical devices require direct sales




There is often an educational/training component to the sales known as the
“learning curve”
Sales and clinical applications personnel often guide physicians through the
learning curve
In some products, sales and clinical applications specialists attend each procedure
at which the device is used




Commonly a sales rep and tech rep send an entire day to assist a single product usage

Some Medical device products/sectors use distributors




Distribution channels vary by clinical area: Eg, spine devices and surgical
instruments tend to use distributors
Commodity type items, such as hospital supplies, tend to use distributors
Distribution channels also vary by geography
 OUS markets tend to be much more distributor dominated

UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE CHANNELS TEND TO BE
DIRECT (2)
 OEMing components to larger manufactures is
generally low margin, hard to exit businesses


The negotiating power lies mainly with the manufacturer

 VARs are virtually non-existent since any alterations
of approved devices require separate clinical trials
and regulatory approvals


EG, adding a steroid to the tip of a pacemaker to prevent fibrosis

 Retail channels exist but solely in consumer products


Hearing aids, eye glasses, wound dressings

UCSF Lean Launchpad - Allan May ©
MARKETING AND SELLING MEDICAL DEVICES
CAN BE A RISKY STRATEGY



Getting and keeping medical device customers often results in
wasteful duplication of resources
GMP manufacturing, quality systems, QA/QC, and sales and
marketing infrastructure are required in order to Market and Sell


These systems and processes are very expensive to finance




Sales people tend to cost >$350-400k/year fully loaded




It normally takes one or more dilutive equity rounds

Clinical applications or technical support specialists are required to
assist sales and marketing

Most acquirers have extensive manufacturing infrastructure and
dedicated sales and marketing forces



So they don’t pay extra value in exits for duplicative resources
They DO pay for proof of penetration and uptake, but that tends to
take >1-2 years and be very expensive in terms of cash burn


Requires substantial funding capital usually from venture capitalists or
corporate venture capital groups

UCSF Lean Launchpad - Allan May ©
ALTERNATIVE STRATEGIES FOR SELLING
MEDICAL DEVICES
 What is it you are trying to prove?




Revenue, or revenue ramp to get a multiple of sales on exit?
KOL uptake?
Clinical viability?

 Building a sales and marketing force and ramping
sales is expensive, risky and time consuming
 A targeted, focused rollout can be equally effective
 Converting key customers of strategics is a very
effective way to get the attention of acquirers






Target hospitals where their KOLs practice
Target major hospitals/customers in their sales channel
Demonstrate physician/patient satisfaction and build clinical
experience

Price/Dreams beats Price/Earnings in most cases!

UCSF Lean Launchpad - Allan May ©
CHANNEL PROFIT FIT IN MEDICAL
DEVICES
 Gross margin impacts distribution method and exit
 First Gen medical devices often have 40-50% margins


Medical device distributors tend to require >25% margins, which is a major reason
distribution is often not a viable channel

 Normally, all available cash in medical device startups is
spent proving safety and efficacy


Cost engineering or cost reduction usually comes in the Series C round or later


It commonly takes 6-12 months (or longer) to reduce costs and maintain safety and
efficacy

 Medical device acquirers will require products with >65%
margins




Sometimes a clear engineering pathway to COGs reductions is sufficient without
actually spending the cash to prove it
Sometimes larger volumes driven by the large sales and marketing forces of major
device companies can achieve COGS and economies of scale unobtainable by
startups

UCSF Lean Launchpad - Allan May ©
UCSF Lean Launchpad For Life Science
and Healthcare Startups
Medical Device Track
Class 3
Channels
October 15, 2013
Allan May
Chairman, Life Science Angels
amay@lifescienceangels.com

UCSF Lean Launchpad - Allan May ©

Contenu connexe

Tendances

Market access the challenges for medical devices
Market access   the challenges for medical devices Market access   the challenges for medical devices
Market access the challenges for medical devices Amy Morgan
 
Digital Marketing for Pharma
Digital Marketing for PharmaDigital Marketing for Pharma
Digital Marketing for PharmaSimon Revell
 
The Digital Metamorphosis of the Pharma Industry
The Digital Metamorphosis of the Pharma IndustryThe Digital Metamorphosis of the Pharma Industry
The Digital Metamorphosis of the Pharma IndustryLen Starnes
 
Best in-class Pharma Marketers
Best in-class Pharma MarketersBest in-class Pharma Marketers
Best in-class Pharma MarketersJean-Michel Peny
 
Pharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysisPharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysisRahul Pagaria
 
UCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and CostsUCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and CostsStanford University
 
Drug value optimization excerpts
Drug value optimization   excerptsDrug value optimization   excerpts
Drug value optimization excerptsJean-Michel Peny
 
Pan (Alkem) Brand Dissertition Presentation
Pan (Alkem) Brand Dissertition PresentationPan (Alkem) Brand Dissertition Presentation
Pan (Alkem) Brand Dissertition PresentationDhaval Vaghela
 
Budget Allocation for a Successful Bio-Pharma Product Launch
Budget Allocation for a Successful Bio-Pharma Product LaunchBudget Allocation for a Successful Bio-Pharma Product Launch
Budget Allocation for a Successful Bio-Pharma Product LaunchBest Practices
 
Best in-class Busines Development & Licensing
Best in-class Busines Development & LicensingBest in-class Busines Development & Licensing
Best in-class Busines Development & LicensingJean-Michel Peny
 
Pharma marketing
Pharma marketingPharma marketing
Pharma marketingUzair Ahmed
 
Future of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectiveFuture of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectivePM Society
 
The future of pharma marketing
The future of pharma marketingThe future of pharma marketing
The future of pharma marketingFarhad Zargari
 
CRE Medical Final NSF I-Corps Presentation
CRE Medical Final NSF I-Corps PresentationCRE Medical Final NSF I-Corps Presentation
CRE Medical Final NSF I-Corps PresentationStanford University
 
Pharmaceuticals Sales Force Effectiveness
Pharmaceuticals Sales Force EffectivenessPharmaceuticals Sales Force Effectiveness
Pharmaceuticals Sales Force EffectivenessBlackdot
 
Porter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma IndustriesPorter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma IndustriesPradeep555
 
Medical devices & surgical disposables in India
Medical devices & surgical disposables in IndiaMedical devices & surgical disposables in India
Medical devices & surgical disposables in IndiaAjjay Kumar Gupta
 

Tendances (20)

Market access the challenges for medical devices
Market access   the challenges for medical devices Market access   the challenges for medical devices
Market access the challenges for medical devices
 
Digital Marketing for Pharma
Digital Marketing for PharmaDigital Marketing for Pharma
Digital Marketing for Pharma
 
The Digital Metamorphosis of the Pharma Industry
The Digital Metamorphosis of the Pharma IndustryThe Digital Metamorphosis of the Pharma Industry
The Digital Metamorphosis of the Pharma Industry
 
Best in-class Pharma Marketers
Best in-class Pharma MarketersBest in-class Pharma Marketers
Best in-class Pharma Marketers
 
Marketing mix of sun pharma
Marketing mix of sun pharmaMarketing mix of sun pharma
Marketing mix of sun pharma
 
Pharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysisPharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysis
 
UCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and CostsUCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
 
Drug value optimization excerpts
Drug value optimization   excerptsDrug value optimization   excerpts
Drug value optimization excerpts
 
Pharma Training Programs
Pharma Training ProgramsPharma Training Programs
Pharma Training Programs
 
Pan (Alkem) Brand Dissertition Presentation
Pan (Alkem) Brand Dissertition PresentationPan (Alkem) Brand Dissertition Presentation
Pan (Alkem) Brand Dissertition Presentation
 
Budget Allocation for a Successful Bio-Pharma Product Launch
Budget Allocation for a Successful Bio-Pharma Product LaunchBudget Allocation for a Successful Bio-Pharma Product Launch
Budget Allocation for a Successful Bio-Pharma Product Launch
 
Patient centric strategy
Patient centric strategyPatient centric strategy
Patient centric strategy
 
Best in-class Busines Development & Licensing
Best in-class Busines Development & LicensingBest in-class Busines Development & Licensing
Best in-class Busines Development & Licensing
 
Pharma marketing
Pharma marketingPharma marketing
Pharma marketing
 
Future of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectiveFuture of Market Access – a Pharma Perspective
Future of Market Access – a Pharma Perspective
 
The future of pharma marketing
The future of pharma marketingThe future of pharma marketing
The future of pharma marketing
 
CRE Medical Final NSF I-Corps Presentation
CRE Medical Final NSF I-Corps PresentationCRE Medical Final NSF I-Corps Presentation
CRE Medical Final NSF I-Corps Presentation
 
Pharmaceuticals Sales Force Effectiveness
Pharmaceuticals Sales Force EffectivenessPharmaceuticals Sales Force Effectiveness
Pharmaceuticals Sales Force Effectiveness
 
Porter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma IndustriesPorter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma Industries
 
Medical devices & surgical disposables in India
Medical devices & surgical disposables in IndiaMedical devices & surgical disposables in India
Medical devices & surgical disposables in India
 

En vedette

USCSF Life Sciences Week 3 Diagnostics: Channel
USCSF Life Sciences Week 3 Diagnostics: ChannelUSCSF Life Sciences Week 3 Diagnostics: Channel
USCSF Life Sciences Week 3 Diagnostics: ChannelStanford University
 
UCSF LIfe Science Week 3 Therapeutics:Channel
UCSF LIfe Science Week 3 Therapeutics:ChannelUCSF LIfe Science Week 3 Therapeutics:Channel
UCSF LIfe Science Week 3 Therapeutics:ChannelStanford University
 
UCSF Life Science Week 3 Digital Health: Channels
UCSF Life Science Week 3 Digital Health: ChannelsUCSF Life Science Week 3 Digital Health: Channels
UCSF Life Science Week 3 Digital Health: ChannelsStanford University
 
UCSF Life Sciences Week 5 Devices: Revenue streams
UCSF Life Sciences Week 5 Devices: Revenue streamsUCSF Life Sciences Week 5 Devices: Revenue streams
UCSF Life Sciences Week 5 Devices: Revenue streamsStanford University
 
UCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsUCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsStanford University
 
UCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnosticsUCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnosticsStanford University
 
UCSF Life Sciences Week 2 devices
UCSF Life Sciences Week 2 devicesUCSF Life Sciences Week 2 devices
UCSF Life Sciences Week 2 devicesStanford University
 
UCSF Life Sciences Week 5 digital health: Revenue streams
UCSF Life Sciences Week 5 digital health: Revenue streamsUCSF Life Sciences Week 5 digital health: Revenue streams
UCSF Life Sciences Week 5 digital health: Revenue streamsStanford University
 
UCSF Life Sciences Week 5 Therapeutics: Revenue Streams
UCSF Life Sciences Week 5 Therapeutics: Revenue StreamsUCSF Life Sciences Week 5 Therapeutics: Revenue Streams
UCSF Life Sciences Week 5 Therapeutics: Revenue StreamsStanford University
 
UCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 DevicesUCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 DevicesStanford University
 
UCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsUCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsStanford University
 
UCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsUCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsStanford University
 
UCSF Life Sciences Week 5 Diagnostics: Revenue models
UCSF Life Sciences Week 5 Diagnostics: Revenue modelsUCSF Life Sciences Week 5 Diagnostics: Revenue models
UCSF Life Sciences Week 5 Diagnostics: Revenue modelsStanford University
 
UCSF Life Sciences Week 1 digital health - Value Proposition
UCSF Life Sciences Week 1 digital health - Value PropositionUCSF Life Sciences Week 1 digital health - Value Proposition
UCSF Life Sciences Week 1 digital health - Value PropositionStanford University
 
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsUCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsStanford University
 
Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Stanford University
 
BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014 BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014 Stanford University
 
Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014Stanford University
 

En vedette (20)

USCSF Life Sciences Week 3 Diagnostics: Channel
USCSF Life Sciences Week 3 Diagnostics: ChannelUSCSF Life Sciences Week 3 Diagnostics: Channel
USCSF Life Sciences Week 3 Diagnostics: Channel
 
UCSF LIfe Science Week 3 Therapeutics:Channel
UCSF LIfe Science Week 3 Therapeutics:ChannelUCSF LIfe Science Week 3 Therapeutics:Channel
UCSF LIfe Science Week 3 Therapeutics:Channel
 
UCSF Life Science Week 3 Digital Health: Channels
UCSF Life Science Week 3 Digital Health: ChannelsUCSF Life Science Week 3 Digital Health: Channels
UCSF Life Science Week 3 Digital Health: Channels
 
UCSF Life Sciences Week 5 Devices: Revenue streams
UCSF Life Sciences Week 5 Devices: Revenue streamsUCSF Life Sciences Week 5 Devices: Revenue streams
UCSF Life Sciences Week 5 Devices: Revenue streams
 
UCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsUCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 Diagnostics
 
UCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnosticsUCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnostics
 
UCSF Life Sciences Week 2 devices
UCSF Life Sciences Week 2 devicesUCSF Life Sciences Week 2 devices
UCSF Life Sciences Week 2 devices
 
UCSF Life Sciences Week 5 digital health: Revenue streams
UCSF Life Sciences Week 5 digital health: Revenue streamsUCSF Life Sciences Week 5 digital health: Revenue streams
UCSF Life Sciences Week 5 digital health: Revenue streams
 
UCSF Life Sciences Week 5 Therapeutics: Revenue Streams
UCSF Life Sciences Week 5 Therapeutics: Revenue StreamsUCSF Life Sciences Week 5 Therapeutics: Revenue Streams
UCSF Life Sciences Week 5 Therapeutics: Revenue Streams
 
UCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 DevicesUCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 Devices
 
UCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsUCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 Therapeutics
 
UCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsUCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer Sements
 
UCSF Life Sciences Week 5 Diagnostics: Revenue models
UCSF Life Sciences Week 5 Diagnostics: Revenue modelsUCSF Life Sciences Week 5 Diagnostics: Revenue models
UCSF Life Sciences Week 5 Diagnostics: Revenue models
 
UCSF Life Sciences Week 1 digital health - Value Proposition
UCSF Life Sciences Week 1 digital health - Value PropositionUCSF Life Sciences Week 1 digital health - Value Proposition
UCSF Life Sciences Week 1 digital health - Value Proposition
 
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsUCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
 
Knox final presentation
Knox final presentationKnox final presentation
Knox final presentation
 
Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10
 
BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014 BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014
 
Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014
 
Clinacuity I-Corps@NIH 121014
Clinacuity I-Corps@NIH 121014Clinacuity I-Corps@NIH 121014
Clinacuity I-Corps@NIH 121014
 

Similaire à UCSF Life Science Week 3 Devices: Channels

UCSF Life Sciences: Week 6 Devices Partnerships
UCSF Life Sciences: Week 6 Devices PartnershipsUCSF Life Sciences: Week 6 Devices Partnerships
UCSF Life Sciences: Week 6 Devices PartnershipsStanford University
 
2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentation2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentationir_stjude
 
2016 analyst and investor day presentation
2016 analyst and investor day presentation2016 analyst and investor day presentation
2016 analyst and investor day presentationir_stjude
 
Stj 2016 analyst and investor day presentation v2
Stj 2016 analyst and investor day presentation v2Stj 2016 analyst and investor day presentation v2
Stj 2016 analyst and investor day presentation v2ir_stjude
 
Vertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaignVertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaignGary Leikin
 
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...LeeSam111
 
Medical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 BerlinMedical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 BerlinGaurav Mishra
 
Market access medical devices-white paper
Market access medical devices-white paperMarket access medical devices-white paper
Market access medical devices-white paperDr. Kavita Lamror
 
Market access medical devices white paper
Market access medical devices white paperMarket access medical devices white paper
Market access medical devices white paperDr. Kavita Lamror
 
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...Hexa Reports
 
The Gemini Generic HIS
The Gemini Generic HISThe Gemini Generic HIS
The Gemini Generic HISThe Gemini
 
IGI Technologies I-Corps@NIH 121014
IGI Technologies I-Corps@NIH 121014IGI Technologies I-Corps@NIH 121014
IGI Technologies I-Corps@NIH 121014Stanford University
 
VentriPoint Diagnostic Ltd. Presentation
VentriPoint Diagnostic Ltd. PresentationVentriPoint Diagnostic Ltd. Presentation
VentriPoint Diagnostic Ltd. PresentationChadLevesque1
 
What is Medical Technology? : 3 Best Ways | The Lifesciences Magazine
What is Medical Technology? : 3 Best Ways  | The Lifesciences MagazineWhat is Medical Technology? : 3 Best Ways  | The Lifesciences Magazine
What is Medical Technology? : 3 Best Ways | The Lifesciences MagazineThe Lifesciences Magazine
 
Equipment Planning in Hospitals
Equipment Planning in HospitalsEquipment Planning in Hospitals
Equipment Planning in HospitalsS A Tabish
 

Similaire à UCSF Life Science Week 3 Devices: Channels (20)

Low fidelitydeck-Team Emergent
Low fidelitydeck-Team EmergentLow fidelitydeck-Team Emergent
Low fidelitydeck-Team Emergent
 
UCSF Life Sciences: Week 6 Devices Partnerships
UCSF Life Sciences: Week 6 Devices PartnershipsUCSF Life Sciences: Week 6 Devices Partnerships
UCSF Life Sciences: Week 6 Devices Partnerships
 
Savita NYU 2015
Savita NYU 2015Savita NYU 2015
Savita NYU 2015
 
HSC_Presentation
HSC_PresentationHSC_Presentation
HSC_Presentation
 
2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentation2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentation
 
2016 analyst and investor day presentation
2016 analyst and investor day presentation2016 analyst and investor day presentation
2016 analyst and investor day presentation
 
Stj 2016 analyst and investor day presentation v2
Stj 2016 analyst and investor day presentation v2Stj 2016 analyst and investor day presentation v2
Stj 2016 analyst and investor day presentation v2
 
Vertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaignVertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaign
 
1660 - Scope Article
1660 - Scope Article1660 - Scope Article
1660 - Scope Article
 
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...
 
Medical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 BerlinMedical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 Berlin
 
MedAid 2017
MedAid 2017MedAid 2017
MedAid 2017
 
Market access medical devices-white paper
Market access medical devices-white paperMarket access medical devices-white paper
Market access medical devices-white paper
 
Market access medical devices white paper
Market access medical devices white paperMarket access medical devices white paper
Market access medical devices white paper
 
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...
 
The Gemini Generic HIS
The Gemini Generic HISThe Gemini Generic HIS
The Gemini Generic HIS
 
IGI Technologies I-Corps@NIH 121014
IGI Technologies I-Corps@NIH 121014IGI Technologies I-Corps@NIH 121014
IGI Technologies I-Corps@NIH 121014
 
VentriPoint Diagnostic Ltd. Presentation
VentriPoint Diagnostic Ltd. PresentationVentriPoint Diagnostic Ltd. Presentation
VentriPoint Diagnostic Ltd. Presentation
 
What is Medical Technology? : 3 Best Ways | The Lifesciences Magazine
What is Medical Technology? : 3 Best Ways  | The Lifesciences MagazineWhat is Medical Technology? : 3 Best Ways  | The Lifesciences Magazine
What is Medical Technology? : 3 Best Ways | The Lifesciences Magazine
 
Equipment Planning in Hospitals
Equipment Planning in HospitalsEquipment Planning in Hospitals
Equipment Planning in Hospitals
 

Plus de Stanford University

Team Networks - 2022 Technology, Innovation & Great Power Competition
Team Networks  - 2022 Technology, Innovation & Great Power CompetitionTeam Networks  - 2022 Technology, Innovation & Great Power Competition
Team Networks - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries  - 2022 Technology, Innovation & Great Power CompetitionTeam LiOn Batteries  - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Quantum - 2022 Technology, Innovation & Great Power Competition
Team Quantum  - 2022 Technology, Innovation & Great Power CompetitionTeam Quantum  - 2022 Technology, Innovation & Great Power Competition
Team Quantum - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
Team Disinformation  - 2022 Technology, Innovation & Great Power CompetitionTeam Disinformation  - 2022 Technology, Innovation & Great Power Competition
Team Disinformation - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Wargames - 2022 Technology, Innovation & Great Power Competition
Team Wargames  - 2022 Technology, Innovation & Great Power CompetitionTeam Wargames  - 2022 Technology, Innovation & Great Power Competition
Team Wargames - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
Team Acquistion  - 2022 Technology, Innovation & Great Power Competition Team Acquistion  - 2022 Technology, Innovation & Great Power Competition
Team Acquistion - 2022 Technology, Innovation & Great Power Competition Stanford University
 
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Stanford University
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedStanford University
 
Invisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedInvisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedStanford University
 
ānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learnedānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons LearnedStanford University
 
Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Stanford University
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Stanford University
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Stanford University
 
Team Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionTeam Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionTeam Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionTeam Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionTeam Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionTeam Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Stanford University
 
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberLecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberStanford University
 

Plus de Stanford University (20)

Team Networks - 2022 Technology, Innovation & Great Power Competition
Team Networks  - 2022 Technology, Innovation & Great Power CompetitionTeam Networks  - 2022 Technology, Innovation & Great Power Competition
Team Networks - 2022 Technology, Innovation & Great Power Competition
 
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries  - 2022 Technology, Innovation & Great Power CompetitionTeam LiOn Batteries  - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
 
Team Quantum - 2022 Technology, Innovation & Great Power Competition
Team Quantum  - 2022 Technology, Innovation & Great Power CompetitionTeam Quantum  - 2022 Technology, Innovation & Great Power Competition
Team Quantum - 2022 Technology, Innovation & Great Power Competition
 
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
Team Disinformation  - 2022 Technology, Innovation & Great Power CompetitionTeam Disinformation  - 2022 Technology, Innovation & Great Power Competition
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
 
Team Wargames - 2022 Technology, Innovation & Great Power Competition
Team Wargames  - 2022 Technology, Innovation & Great Power CompetitionTeam Wargames  - 2022 Technology, Innovation & Great Power Competition
Team Wargames - 2022 Technology, Innovation & Great Power Competition
 
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
Team Acquistion  - 2022 Technology, Innovation & Great Power Competition Team Acquistion  - 2022 Technology, Innovation & Great Power Competition
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
 
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons Learned
 
Invisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedInvisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons Learned
 
ānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learnedānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learned
 
Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionTeam Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power Competition
 
Team Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionTeam Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power Competition
 
Team Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionTeam Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power Competition
 
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionTeam Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
 
Team Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionTeam Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power Competition
 
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
 
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberLecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
 

Dernier

Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 

Dernier (20)

Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 

UCSF Life Science Week 3 Devices: Channels

  • 1. UCSF Lean Launchpad For Life Science and Healthcare Startups Medical Device Track Class 3 Channels October 15, 2013 Allan May Chairman, Life Science Angels amay@lifescienceangels.com UCSF Lean Launchpad - Allan May ©
  • 2. MEDICAL DEVICE MARKETS ARE PHYSICAL MARKETS  Medical devices encompass a large range of tangible and intangible items with a wide variety of business models and issues          Imaging equipment, such as MRI, CT and ultrasound Therapeutic capital equipment, such as Stereotactic radiosurgery, lasers, and surgical robots Implants, such as total joints, pacemakers, stents, and artificial corneas Instruments and tools, such as scalpels, syringes, and electrocautery Devices, such as catheters, introducers, and sheaths Monitoring equipment, such as glucometers, pulse oximetry, and vital signs monitors Durable medical equipment, such as crutches, wheelchairs, and home oxygen Disposables, such as syringes, wound dressings, and casts Medical devices generally require physical delivery  Exceptions:  Software based products  Morpheus: Enhanced imaging data via post processing  Physician office management software  Big Data based products UCSF Lean Launchpad - Allan May ©
  • 3. MEDICAL DEVICE CHANNELS TEND TO BE DIRECT   Most devices are sold to hospitals, physicians or patients directly Most medical devices require direct sales    There is often an educational/training component to the sales known as the “learning curve” Sales and clinical applications personnel often guide physicians through the learning curve In some products, sales and clinical applications specialists attend each procedure at which the device is used   Commonly a sales rep and tech rep send an entire day to assist a single product usage Some Medical device products/sectors use distributors    Distribution channels vary by clinical area: Eg, spine devices and surgical instruments tend to use distributors Commodity type items, such as hospital supplies, tend to use distributors Distribution channels also vary by geography  OUS markets tend to be much more distributor dominated UCSF Lean Launchpad - Allan May ©
  • 4. MEDICAL DEVICE CHANNELS TEND TO BE DIRECT (2)  OEMing components to larger manufactures is generally low margin, hard to exit businesses  The negotiating power lies mainly with the manufacturer  VARs are virtually non-existent since any alterations of approved devices require separate clinical trials and regulatory approvals  EG, adding a steroid to the tip of a pacemaker to prevent fibrosis  Retail channels exist but solely in consumer products  Hearing aids, eye glasses, wound dressings UCSF Lean Launchpad - Allan May ©
  • 5. MARKETING AND SELLING MEDICAL DEVICES CAN BE A RISKY STRATEGY   Getting and keeping medical device customers often results in wasteful duplication of resources GMP manufacturing, quality systems, QA/QC, and sales and marketing infrastructure are required in order to Market and Sell  These systems and processes are very expensive to finance   Sales people tend to cost >$350-400k/year fully loaded   It normally takes one or more dilutive equity rounds Clinical applications or technical support specialists are required to assist sales and marketing Most acquirers have extensive manufacturing infrastructure and dedicated sales and marketing forces   So they don’t pay extra value in exits for duplicative resources They DO pay for proof of penetration and uptake, but that tends to take >1-2 years and be very expensive in terms of cash burn  Requires substantial funding capital usually from venture capitalists or corporate venture capital groups UCSF Lean Launchpad - Allan May ©
  • 6. ALTERNATIVE STRATEGIES FOR SELLING MEDICAL DEVICES  What is it you are trying to prove?    Revenue, or revenue ramp to get a multiple of sales on exit? KOL uptake? Clinical viability?  Building a sales and marketing force and ramping sales is expensive, risky and time consuming  A targeted, focused rollout can be equally effective  Converting key customers of strategics is a very effective way to get the attention of acquirers     Target hospitals where their KOLs practice Target major hospitals/customers in their sales channel Demonstrate physician/patient satisfaction and build clinical experience Price/Dreams beats Price/Earnings in most cases! UCSF Lean Launchpad - Allan May ©
  • 7. CHANNEL PROFIT FIT IN MEDICAL DEVICES  Gross margin impacts distribution method and exit  First Gen medical devices often have 40-50% margins  Medical device distributors tend to require >25% margins, which is a major reason distribution is often not a viable channel  Normally, all available cash in medical device startups is spent proving safety and efficacy  Cost engineering or cost reduction usually comes in the Series C round or later  It commonly takes 6-12 months (or longer) to reduce costs and maintain safety and efficacy  Medical device acquirers will require products with >65% margins   Sometimes a clear engineering pathway to COGs reductions is sufficient without actually spending the cash to prove it Sometimes larger volumes driven by the large sales and marketing forces of major device companies can achieve COGS and economies of scale unobtainable by startups UCSF Lean Launchpad - Allan May ©
  • 8. UCSF Lean Launchpad For Life Science and Healthcare Startups Medical Device Track Class 3 Channels October 15, 2013 Allan May Chairman, Life Science Angels amay@lifescienceangels.com UCSF Lean Launchpad - Allan May ©